Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Parisian biotech specialist in oncological nanomedicine signs the largest decline of the extended index in mid-morning, in a downward-oriented mar…
The Parisian biotech company posts the strongest gain on the broader index at midday, in a market oriented downwards. This rebound comes after a very …
The Parisian biotech company specializing in nanomedical oncology is posting a sharp decline this Friday, marking the worst performance of the SBF 120…
The Parisian biotech company specializing in nanomedical oncology is posting a significant decline this Thursday, in an SBF 120 index also declining. …
The oncological nanomedicine biotech stock experienced the steepest decline on the broader index on Monday morning, breaching a key technical threshol…
Nanobiotix published on September 24, 2026 its operational and financial update for the first half of 2026. The Paris-based biotech company specializi…
The Parisian biotech company specializing in oncological nanomedicine is among the most neglected values of the SBF 120 this Thursday, as the index de…
The Parisian biotech company specializing in nanomedicine oncology is posting one of the best performances on the French stock exchange this Wednesday…
The Paris-based biotech is declining this Monday in an SBF 120 that is nonetheless in slight positive territory, extending a difficult sequence that b…
The Paris-based biotech company is losing ground this Wednesday in a slightly positive SBF 120, thus moving counter to the broader index trend. The st…
